Recalls
Searchable archive of product recalls from the FDA, USDA FSIS, CPSC, NHTSA, and EPA — translated into plain English, severity-scored from objective criteria, and always linked back to the original government notice.
Every recall on this list has been scored 1–5 against an objective rubric from the agency’s own classification, presence of reported injuries or deaths, distribution scope, and hazard type. The colored severity badge on each card is the score — 5 (Critical) means deaths or serious injuries are reported, 4 (Severe) means significant injury or hospitalization risk, and 3 (High) means a known hazard with no confirmed harm yet. Filter to 3+ (High and above) if you want to skip routine Class-III notices.
The agency chips above control which streams are visible. FDA spans food, drugs, and medical devices. USDA FSIS is meat, poultry, and processed egg products. CPSC is household consumer products. NHTSA is vehicles, tires, and child seats. Nationwide on a card means the recall affects every US state — most do — while a state list means distribution was limited.
Click any recall to see the full summary, affected lot codes and model numbers, the agency’s own classification, and a direct link back to the original government notice for verification.
Minimum severity
Medline Industries is recalling Aplicare Povidone-Iodine Prep Pads because the iodine content is below the labeled claim.
Taro Pharmaceuticals is recalling 27,792 tubes of Clobetasol Propionate Cream 0.05% because the product failed content uniformity specifications.
Medline Industries is recalling 288 cases of Newborn Kits because the Povidone-Iodine prep pads contain subpotent iodine, falling below the 0.85% label claim.
Ascent Pharmaceuticals is recalling 45,875 bottles of Oxycodone Hydrochloride 15 mg tablets because the label is missing the required controlled substance symbol.
AbbVie Inc. is recalling 7,770 bottles of Ultane (sevoflurane) inhalation anesthetic due to defective container caps that may leak.
Fresenius Kabi USA is recalling 35,620 vials of Vecuronium bromide for Injection due to an out-of-specification result for a related compound.
Dr. Reddy's is recalling 12,579 bottles of Atorvastatin Calcium 40 mg tablets because they failed impurity specifications during stability testing.
A&H Focal Inc. is recalling Indian God Lotion Spray Bottles because the product is an unapproved drug containing diethyl phthalate.
Dr. Reddy's Laboratories is recalling Atorvastatin Calcium 10 mg tablets because stability testing showed out-of-specification results for total degradation impurities.
Dr. Reddy's Laboratories is recalling Atorvastatin Calcium 20 mg tablets because stability testing revealed out-of-specification total degradation impurities.
The FDA is recalling Hard Times For Men capsules because they contain undeclared sildenafil and were marketed without an approved NDA or ANDA.
BotanicalNow is recalling BodySlim Herbal capsules because FDA analysis found undeclared sibutramine, a substance not approved for use in this product.
International Laboratories, Inc. is recalling Pravastatin Sodium Tablets 10 mg because bottles may contain 20 mg tablets.
Sun Pharmaceutical Industries is recalling 393 vials of Doxorubicin Hydrochloride Liposome Injection due to a lack of assurance of sterility.
Advanced Pharma Inc. is recalling 25 bags of Magnesium Sulfate IV solution in Texas due to subpotent product.
International Laboratories, Inc. is recalling Pravastatin Sodium Tablets, 20 mg, because bottles may contain 10 mg tablets. Patients should contact their healthcare provider.
DLC Laboratories is recalling Earth's Care Eczema Lotion due to microbial contamination. The product was distributed nationwide.
Odan Laboratories is recalling 179 kits of Dry to Normal Skin Starter Kit because the product failed stability specifications at 12 months.
Odan Laboratories is recalling 21 jars of Day Cream SPF15 because the product failed stability specifications at 12 months.
Marksans Pharma Inc. is recalling 4,127,500 ibuprofen tablets due to odor complaints and CGMP deficiencies. The product was distributed nationwide to repackaging firms.
Marksans Pharma Inc. is recalling 205,088,000 ibuprofen tablets due to odor complaints linked to CGMP deficiencies. The product was distributed nationwide in the USA.
Marksans Pharma Inc. is recalling specific lots of 600 mg ibuprofen tablets due to odor complaints linked to CGMP deficiencies.
Marksans Pharma Inc. is recalling 52,549,000 ibuprofen tablets due to odor complaints and CGMP deficiencies. The product was distributed nationwide.
Marksans Pharma Inc. is recalling 21,584,100 Ibuprofen Tablets, USP 400 mg, due to odor complaints linked to CGMP deficiencies.
Marksans Pharma Inc. is recalling ibuprofen tablets due to odor complaints linked to Current Good Manufacturing Practice (CGMP) deficiencies.